Strategic Initiative

Slingshot members are tracking this corporate initiative:

Geron (GERN) Announces $80M License Deal with Janssen (JNJ) to Develop and Commercialize Products Based on GERN's Specialized Oligonucleotide Backbone Chemistry and RNA Interference Candidates for Treatment of Numerous Human Disorders

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ

100%
GERN

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Sep 19, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords License Deal, Specialized Oligonucleotide Backbone, Rna Interference Candidates, Numerous Human Disorders